This work aims to evaluate the regenerative potential of platelet-rich plasma (PRP) on an implant site of peculiar clinical impact, such as sinus augmentation.
A restrictive transfusion strategy in appropriate at-risk ICU patients may be effective in mitigating the magnitude of this clinical and economic burden.